Jan 11 (Reuters) - Establishment Labs Holdings Inc
ESTA.O :
* ESTABLISHMENT LABS HOLDINGS INC - EXPECTS TO ACHIEVE $500
MILLION IN ANNUAL REVENUE IN FISCAL YEAR 2026
* ESTABLISHMENT LABS HOLDINGS INC - NOTIFIED FDA THAT IT WAS
READY
TO SUBMIT MODULE 4 OF PMA TO COMMERCIALIZE MOTIVA IMPLANTS IN
U.S. BEFORE END OF 2022
* ESTABLISHMENT LABS HOLDINGS INC - CO, FDA HAVE BEEN
WORKING
COLLABORATIVELY ON OPTIMAL TIMING TO SUBMIT FINAL MODULE
* ESTABLISHMENT LABS HOLDINGS INC - EXPECTS TO FILE MODULE 4
DURING Q1 OF 2023
Source text for Eikon: ID:
Further company coverage: ESTA.O
((reuters.briefs@thomsonreuters.com;))